Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability Study.

Jabagi MJ, Bertrand M, Gabet A, Tréluyer L, Kolla E, Rachas A, Olié V, Zureik M

Open source

DOI
10.1016/j.lanepe.2026.101756
Published
2026 Aug
Container
The Lancet regional health. Europe
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2026.101756,
  title = {Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability Study.},
  author = {Jabagi MJ and Bertrand M and Gabet A and Tréluyer L and Kolla E and Rachas A and Olié V and Zureik M},
  year = {2026},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2026.101756},
  url = {https://doi.org/10.1016/j.lanepe.2026.101756}
}

RIS

TY  - JOUR
TI  - Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability Study.
AU  - Jabagi MJ
AU  - Bertrand M
AU  - Gabet A
AU  - Tréluyer L
AU  - Kolla E
AU  - Rachas A
AU  - Olié V
AU  - Zureik M
PY  - 2026
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2026.101756
UR  - https://doi.org/10.1016/j.lanepe.2026.101756
ER  - 

APA

MJ, J., M, B., A, G., L, T., E, K., A, R., V, O., & M, Z. (2026). Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability Study.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2026.101756

Source records